<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04486248</url>
  </required_header>
  <id_info>
    <org_study_id>ASL/BBRC2019</org_study_id>
    <nct_id>NCT04486248</nct_id>
  </id_info>
  <brief_title>Comparison of Magnetic Resonance Techniques for the Measurement of Cerebral Blood Perfusion</brief_title>
  <official_title>Comparison of Magnetic Resonance Techniques for the Measurement of Cerebral Blood Perfusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barcelonabeta Brain Research Center, Pasqual Maragall Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barcelonabeta Brain Research Center, Pasqual Maragall Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this project, we aim at implementing a te-ASL sequence and to compare it to two reference
      ASL sequences with a fixed PLD on healthy individuals. On the one hand, the te-ASL sequence
      will be compared against a 3D pCASL with a PLD of 1800 ms, as the current reference according
      the Consensus of the ISMRM perfusion study group and the European consortium for ASL in
      dementia. On the other, as the implemented te-ASL sequence will have a 2D readout, it will
      also be compared to a 2D pCASL ASL sequence with the same PLD, in order to be able to
      disentangle differences due to the dynamic PLD scheme from those arising from the different
      read-out schemes.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 9, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Actual">February 24, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ASL perfusion MRI data</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Quantification of cerebral blood flow</description>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Healthy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Thirty (N=30) healthy individuals older than 18 years old
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To sign the study informed consent form approved by the corresponding authorities.

          -  Healthy men and women (older than 18 years old).

        Exclusion Criteria:

          -  Inability or unwillingness to give written informed consent or communicate with the
             study staff or illiteracy.

          -  Any contraindication to perform brain MRI procedure (e.g. pacemaker, MRI-incompatible
             aneurysm clips).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>BarcelonaBeta Brain Research Center</name>
      <address>
        <city>Barcelona</city>
        <zip>08005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 20, 2020</study_first_submitted>
  <study_first_submitted_qc>July 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2020</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

